Mode
Text Size
Log in / Sign up
N/A Completed N=118 Single-blind Treatment

Assessment of Lotrafilcon A Contact Lenses

Source: ClinicalTrials.gov NCT01185834 ↗
Enrolled (actual)
118
Serious AEs
0.0%
Results posted
Jan 2012
Primary outcomePrimary: Overall Comfort — 8.4 units on a scale

Summary

The purpose of this 3-month study is to evaluate subjective responses to an upgraded contact lens.

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Comfort
8.4 —
SECONDARY
Overall Lens Fit
0.0 —

Eligibility Criteria

Inclusion Criteria

  • Have normal ocular findings.
  • Be able to wear the study lenses in the available powers.
  • Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day.
  • Wear Night & Day contact lenses.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • Require concurrent ocular medication.
  • Eye injury or surgery within twelve weeks prior to enrollment.
  • Currently enrolled in an ophthalmic clinical trial.
  • Any active corneal infection.
  • Corneal refractive surgery.
  • Wear AIR OPTIX NIGHT & DAY AQUA lenses.
  • Other protocol-defined exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01185834). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search